73253-27-7

Basic information

• Product Name: (6R)-3-acetoxymethyl-8-oxo-7t-[(R)-2-(6-oxo-1,2-dihydro-6H-pyrrolo[3,2,1-ij]quinoline-5-carbonylamino)-2-phenyl-acetylamino]-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• CAS NO: 73253-27-7
• Molecular Weight: 602.624
• Mol File: 73253-27-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (6R)-3-acetoxymethyl-8-oxo-7t-[(R)-2-(6-oxo-1,2-dihydro-6H-pyrrolo[3,2,1-ij]quinoline-5-carbonylamino)-2-phenyl-acetylamino]-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (6R)-3-acetoxymethyl-8-oxo-7t-[(R)-2-(6-oxo-1,2-dihydro-6H-pyrrolo[3,2,1-ij]quinoline-5-carbonylamino)-2-phenyl-acetylamino]-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid(73253-27-7)
• EPA Substance Registry System: (6R)-3-acetoxymethyl-8-oxo-7t-[(R)-2-(6-oxo-1,2-dihydro-6H-pyrrolo[3,2,1-ij]quinoline-5-carbonylamino)-2-phenyl-acetylamino]-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid(73253-27-7)

Safety Data

• Hazardous Substances Data: 73253-27-7(Hazardous Substances Data)

Upstream product

• 40400-68-8 6-oxo-1,2-dihydro-6H-pyrrolo[3,2,1-ij]quinoline-5-carboxylic acid 
• 3577-01-3 cephaloglycin 
• 543-27-1 isobutyl chloroformate 

Relevant articles and documents

β-Lactam series compound and antibacterial pharmaceutical composition containing the same

A β-lactam series compound represented by the formula (I): STR1 wherein R1 represents a hydrogen atom or a lower alkyl group; R2 represents a hydrogen atom; R3 represents a halogen atom, a nitro group, an amino group, a hydroxy group, a lower alkyl group, a lower alkoxy group, a lower alkanoylamino group, a lower alkanesulfonyloxy group or a group represented by the formula STR2 where R5 represents a hydrogen atom, a lower alkanoyl group, or a lower alkanesulfonyl group; R4 represents a hydrogen atom or a hydroxy group; n is 0 or 1; l is 0, 1 or 2; and A represents --C(CH3)2 --CH(COOH)-- or --CH2 C(CH2 R6)=C(COOH)-- where R6 represents a lower alkanoyloxy group, a group represented by the formula STR3 where R7 and R8 each represents a lower alkyl group and when n is 0, R1 and R2 can combine to form a cyclohexane ring together with the carbon atoms to which they are attached, and pharmaceutically acceptable salts thereof as well as a method for preparing same are disclosed. These compounds have antimicrobial activity.